Allianz Eyes November Results as Buyback Rolls On and Leadership Roster Takes Shape

Allianz sets 12 November 2026 for Q3 figures as shares close at EUR 417.60; buybacks continue and Berenberg keeps Buy with EUR 684 target.

Allianz SE will open its books on 12 November 2026, when the Munich insurer publishes third-quarter figures — a date that now anchors the market's near-term attention. The stock finished Friday's session at EUR 417.60, a gain of 1.4%, as trading settled after a stretch of profit-taking.

That recovery came against a backdrop of jitters over new technologies. Speculation surrounding Meta's AI agent, dubbed "Muse," rippled through the market and stirred worries about disruption across the services sector, briefly dragging financial and insurance names — including this one — under selling pressure despite an absence of negative company news. The episode says more about prevailing nerves over technological upheaval than about anything happening inside the group, where there are no signs of operational strain. Market participants had used the earlier levels to lock in gains after the stock spent much of the year riding a firm sector cycle. Year to date, the shares remain up 6.6%.

Capital Returns Keep Running

The buyback machine has stayed busy. Between 21 and 22 September, the company repurchased another 182,616 of its own shares, lifting the total acquired since 13 March to 6,247,961. By shrinking the number of shares in circulation, the program steadily trims the equity base and, with earnings held constant, flatters per-share metrics. Management has been running this playbook as a deliberate tool for steering capital structure.

Boardroom and Subsidiary Changes

Alongside the capital measures, Allianz is putting its long-term leadership architecture in place. Tomas Kunzmann is slated to join the board of Allianz SE on 1 January 2027. At the subsidiaries, Philipp Kroetz takes over as CEO of Allianz Partners on 1 November 2026, with Laurent Floquet moving to the helm of Allianz Direct on the same date. At Allianz Commercial, Stephen Morton is earmarked to lead Captive Fronting and Captive Solutions from 1 March 2027. All appointments remain subject to regulatory approval.

On the product side, the group's private health insurance arm introduced "MeinKrankenhausschutz," an inpatient supplementary tariff with three benefit tiers. Selected existing customers are being offered a switching option without a fresh health check, valid until 31 December 2026. Allianz also rolled out the 17th edition of its Global Wealth Report, which examines household finances across nearly 60 countries.

Berenberg Sticks With Its Call

Analyst Michael Huttner of Berenberg reiterated a "Buy" rating and a EUR 684 price target, pointing to expected earnings growth through the end of the 2027 strategic plan. The stock is trading in the middle of its medium-term range. Its 200-day moving average sits at EUR 397.06, a solid support line beneath the current level, while the 52-week high of EUR 454.50, reached on 3 September 2026, serves as the key chart marker overhead.

Fund Arm Flags Cautious Outlook

How the broader picture looks for institutional investors was laid out Wednesday by Allianz Global Investors in its fourth-quarter 2026 outlook. The global economy is entering the final stretch of the year with renewed growth momentum, the asset manager said — but its investment experts counsel caution, warning that lingering inflation risks and geopolitical uncertainty could still leave financial markets exposed.